【摘要】 目的探讨舟山海岛地区口服药物结合手法复位治疗良性发作性位置性眩晕的临床疗效。方法选取2017年9月至2019年8月我院神经内科、康复医学科门诊及住院诊断为良性发作性位置性眩晕患者112例,根据所选择的治疗方法将其分为对照组和治疗组,每组各56例。对照组仅口服甲磺酸倍他司汀片,治疗组口服甲磺酸倍他司汀片联合手法复位。治疗周期为1周。1周后评价两组治疗效果。结果经治疗后,治疗组治疗总有效率为89.29%,明显高于对照组的57.14%,差异有统计学意义(P<0.05)。治疗前两组患者的眩晕症状评分比较,差异无统计学意义(P>0.05);治疗1周后,两组患者的眩晕症状评分均较治疗前显著降低(P<0.05),且治疗后的治疗组眩晕症状评分显著低于对照组,差异有统计学意义(P<0.05)。结论单纯口服药物及联合治疗方案均能改善良性发作性位置性眩晕症状,口服倍他司汀片结合手法复位治疗方案疗效更优。更多还原

【Abstract】 Objective To investigate the clinical efficacy of oral medication combined with manual reduction in the treatment of benign paroxysmal positional vertigo in Zhoushan Island area. Methods A total of 112 patients with paroxysmal positional vertigo from September 2017 to August 2019 were selected from outpatient and inpatient services of neurology department and rehabilitation medicine department of our hospital were selected. They were divided into the control group and the treatment group according the treatment chosen,with 56 patients in each group. The control group was given betastatin mesylate tablets only, and the treatment group was given betastatin mesylate tablets combined with manipulative reduction. The treatment cycle was 1 week. Treatment effect was evaluated 1 week later. Results After treatment,the total effective rate in the treatment group was 89.29%, which was higher than that of 57.14% in the control group, with significant difference(P<0.05). There was no significant difference of the clinical symptoms score between the two groups before the treatment(P>0.05). After 1 week of treatment,the clinical symptoms score of both groups decreased more significantly than that before the treatment(P<0.05), and the clinical symptoms score in the treatment group was significantly lower than that in the control group, with significant difference(P<0.05). Conclusion Both oral medication alone and combined treatment regimen can improve the symptoms of benign paroxysmal positional vertigo,and oral betastatin combined with manipulative reduction regimen is more effective.更多还原